41, 45, 46 Studies conducted in patients with stroke younger than 65 years reported age-favorable clinical outcomes associated with prior TIA.
The aerial gravity survey leads to the delineation of 14 large closed anticlinal structures, comprising thick deltaic sedimentary succession of Neogene age with favorable geological prospect, viz., Rokhia, Tichna, Gojalia, Baramura, Tulamura, Atharamura, Batchia, Langtarai, Harargaj, Machlithum, Khubal, Skham, Langai, and Jampai anticlines (Fig. 3).
This study shows that treating physicians should start treatment of CHC patients at an early age for favorable response.
6 Moreover, the therapeutic effects of hypomethylating agents are not related to patient age; indeed, favorable responses have been achieved in patients over 75 years of age, 15 such as in our patient.
The assumption that aging is favorable for evolvability [ 9, 11, 12, 17] presumes that natural selection fails to eliminate traits of the aging program that increase evolvability but are counterproductive for individuals.
Patients aged over 70 years with favorable KPS, or patients aged 60 70 years with borderline KPS, should be considered for monotherapy utilizing standard TMZ dosing for patients with MGMT-methylated tumors, and hypofractionated RT (34 Gy in ten fractions or 40 Gy in 15 fractions) for patients with MGMT-unmethylated tumors.
Thus, for patients aged over 70 years with favorable performance status, or for patients aged 60 years or older with borderline performance status, we recommend maximal safe resection, MGMT testing, and then consideration of monotherapy with either TMZ or hypofractionated RT, or hypofractionated RT concurrently with TMZ.
Increasing age suggested more favorable MCS scores and less favorable PCS scores in both active-duty and Reserve/National Guard women.
For patients aged over 70 years with favorable KPS, there is a clearly defined survival benefit to longer-course RT to 50 Gy as compared with best supportive care, 32 so patients with favorable KPS should certainly be offered some form of tumor-directed treatment.
The results for patients in the IST group were less clear because advanced age was a favorable factor in 3 studies and young age a favorable factor in 2 studies.
The optimism is anchored by India's favorable age profile.
